Quality and composition of archived nucleic acids after use in SARS-CoV-2 molecular testing
Copyright © 2023 Elsevier B.V. All rights reserved..
BACKGROUND: Reverse transcription real-time PCR (rRT-PCR) has been a gold-standard method to detect SARS-CoV-2, for which quality assessment of nucleic acids (NAs) is not needed. In order to prepare for future use, we evaluated NA quality from archived SARS-CoV-2 rRT-PCR samples.
METHODS: NA samples were collected in February 2021 and extracted using the QIAamp DSP Virus Spin Kit, (53 SARS-CoV-2-positive and 100 SARS-CoV-2-negative). Quality, quantity, and purity of NA were measured spectrophotometrically or fluorescently. Droplet digital PCR was used to characterize the double strand DNA (dsDNA) origin and composition by quantifying 16S rDNA and RPP30.
RESULTS: The RIN and purity were not significantly different between groups (p = 0.3828). RNA quantity was significantly higher than dsDNA in both groups (p < 0.0001); both dsDNA and RNA quantity were significantly higher in positive samples (dsDNA, RNA p = 0.021). For dsDNA, 16S rDNA copies were significantly greater than RPP30 in both groups (p < 0.0001), and RPP30 were significantly higher in positive samples (p < 0.0001).
CONCLUSIONS: Archived NA quality after SARS-CoV-2 rRT-PCR was guaranteed for subsequent molecular research using human or bacterial DNA, especially for short targets.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:554 |
---|---|
Enthalten in: |
Clinica chimica acta; international journal of clinical chemistry - 554(2024) vom: 01. Feb., Seite 117755 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Song, Ho Hyun [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 05.02.2024 Date Revised 05.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.cca.2023.117755 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM366726900 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM366726900 | ||
003 | DE-627 | ||
005 | 20240205232021.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240108s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.cca.2023.117755 |2 doi | |
028 | 5 | 2 | |a pubmed24n1281.xml |
035 | |a (DE-627)NLM366726900 | ||
035 | |a (NLM)38182077 | ||
035 | |a (PII)S0009-8981(23)00557-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Song, Ho Hyun |e verfasserin |4 aut | |
245 | 1 | 0 | |a Quality and composition of archived nucleic acids after use in SARS-CoV-2 molecular testing |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.02.2024 | ||
500 | |a Date Revised 05.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier B.V. All rights reserved. | ||
520 | |a BACKGROUND: Reverse transcription real-time PCR (rRT-PCR) has been a gold-standard method to detect SARS-CoV-2, for which quality assessment of nucleic acids (NAs) is not needed. In order to prepare for future use, we evaluated NA quality from archived SARS-CoV-2 rRT-PCR samples | ||
520 | |a METHODS: NA samples were collected in February 2021 and extracted using the QIAamp DSP Virus Spin Kit, (53 SARS-CoV-2-positive and 100 SARS-CoV-2-negative). Quality, quantity, and purity of NA were measured spectrophotometrically or fluorescently. Droplet digital PCR was used to characterize the double strand DNA (dsDNA) origin and composition by quantifying 16S rDNA and RPP30 | ||
520 | |a RESULTS: The RIN and purity were not significantly different between groups (p = 0.3828). RNA quantity was significantly higher than dsDNA in both groups (p < 0.0001); both dsDNA and RNA quantity were significantly higher in positive samples (dsDNA, RNA p = 0.021). For dsDNA, 16S rDNA copies were significantly greater than RPP30 in both groups (p < 0.0001), and RPP30 were significantly higher in positive samples (p < 0.0001) | ||
520 | |a CONCLUSIONS: Archived NA quality after SARS-CoV-2 rRT-PCR was guaranteed for subsequent molecular research using human or bacterial DNA, especially for short targets | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Nucleic Acids |2 NLM | |
650 | 7 | |a RNA, Viral |2 NLM | |
650 | 7 | |a DNA, Ribosomal |2 NLM | |
700 | 1 | |a Choi, Jong Cheul |e verfasserin |4 aut | |
700 | 1 | |a Lee, Ran |e verfasserin |4 aut | |
700 | 1 | |a Yoon, Sook Kyung |e verfasserin |4 aut | |
700 | 1 | |a Park, Hye Jeong |e verfasserin |4 aut | |
700 | 1 | |a Shin, Young Hee |e verfasserin |4 aut | |
700 | 1 | |a Shin, Jeong Won |e verfasserin |4 aut | |
700 | 1 | |a Kim, Jieun |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinica chimica acta; international journal of clinical chemistry |d 1956 |g 554(2024) vom: 01. Feb., Seite 117755 |w (DE-627)NLM000002054 |x 1873-3492 |7 nnns |
773 | 1 | 8 | |g volume:554 |g year:2024 |g day:01 |g month:02 |g pages:117755 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cca.2023.117755 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 554 |j 2024 |b 01 |c 02 |h 117755 |